top of page

The Data Trap: Why Pharma Leaders See Change Too Late

Updated: 22 hours ago

๐Ÿ”ท๐–๐ก๐ฒ ๐๐จ ๐œ๐จ๐ฆ๐ฆ๐ž๐ซ๐œ๐ข๐š๐ฅ ๐๐š๐ฌ๐ก๐›๐จ๐š๐ซ๐๐ฌ ๐š๐ฅ๐ฐ๐š๐ฒ๐ฌ ๐ฌ๐ก๐จ๐ฐ ๐œ๐ก๐š๐ง๐ ๐ž ๐ญ๐จ๐จ ๐ฅ๐š๐ญ๐ž?


Data availability in Pharma is rarely the problem. The real challenge is ๐ญ๐ข๐ฆ๐ข๐ง๐ .


Many leadership teams are surprised by "sudden" market shifts, not because the data wasn't there, but because they were looking at the ๐ฐ๐ซ๐จ๐ง๐  ๐ฌ๐ข๐ ๐ง๐š๐ฅ.


We tend to focus on ๐๐ซ๐ž๐ฌ๐œ๐ซ๐ข๐›๐ข๐ง๐  ๐๐š๐ญ๐ญ๐ž๐ซ๐ง๐ฌ (what happened), when we should be analyzing ๐๐ซ๐ž๐ฌ๐œ๐ซ๐ข๐›๐ข๐ง๐  ๐๐ž๐ก๐š๐ฏ๐ข๐จ๐ฎ๐ซ (how the system is changing).


In my latest article, I break down:ย 


๐Ÿ”น The critical difference between Pattern and Behaviour.ย 

๐Ÿ”น Why NHS data reveals change months before commercial KPIs.ย 

๐Ÿ”น How to distinguish "noise" from "structural momentum."


Change is visible earlier if you know where to look.

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page